NeutraSal Treatment for Xerostomia in OSAS Patients Using CPAP Therapy

Completed · Not applicable · Has a placebo group

Conditions studied: Xerostomia

In brief

To assess whether the daily use of NeutraSal will prevent or reduce dry mouth in patients undergoing CPAP therapy for OSAS and improve CPAP compliance

Key facts

Study ID

NCT02107300

Run by

Medical University of South Carolina

People needed

32

Starts

2013-11-01

Expected to finish

2017-07-03

Last updated by the study team

2018-12-11

Who can join

Age: 18 and older, up to 84. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient should be above 18 years of age.
• Patients who have been initiated on CPAP therapy after an initial diagnosis of OSAS and have developed dry mouth or have worsening of pre-existing dry mouth condition, as an effect of CPAP therapy.
• Ability to attend visits at the research site
• Patient should be able to read and/or understand and sign the consent form be willing to participate in the research study

You may not qualify if…

• Patients with open mouth sores at study entry.
• Any pathology that, based on the judgement of the researcher, could negatively affect the oral mucosa and subsequent treatment for xerostomia (immune disorders, etc.)
• Patients using any other prophylactic mouthwashes.
• Patients who are pregnant and/or nursing.
• Patients becoming pregnant during the treatment period will be removed from data.
• Patients on a low sodium diet
• Patients currently on medication or treatment for xerostomia
• Patients < 18 years of age
• Hypersensitivity to any of the following ingredients- sodium chloride, sodium phosphate, calcium chloride and sodium bicarbonate

Where it is running

• Medical University of South Carolina — Charleston, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.